Patient Guide: A Study of AZD0486 Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 63 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06549595
Status: 🟢 Enrolling Now
Condition: Untreated Follicular Lymphoma
Phase: PHASE3

Where You Can Participate

This study is available at 63 locations across the country.

Top locations include:
  • • Macquarie University,
  • • Nedlands,
  • • Brussels,
  • • And 60 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of AZD0486 Plus Rituximab in Previously Untreated Follicular Lymphoma Patients - Join Clinical Trial NCTNCT06549595

How to Join This Clinical Trial - NCTNCT06549595

Learn how to participate in this PHASE3 trial studying an investigational therapy for Untreated Follicular Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Untreated Follicular Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Untreated Follicular Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06549595 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 63 locations. Find a study site near you:

Clinical Research Site

Macquarie University, 2109 - Australia

Status: RECRUITING

Clinical Research Site

Nedlands, 6009 - Australia

Status: RECRUITING

Clinical Research Site

Brussels, 1070 - Belgium

Status: NOT_YET_RECRUITING

Clinical Research Site

Brussels, 1090 - Belgium

Status: NOT_YET_RECRUITING

Clinical Research Site

Gent, 9000 - Belgium

Status: NOT_YET_RECRUITING

Clinical Research Site

Mechelen, 2800 - Belgium

Status: NOT_YET_RECRUITING

Clinical Research Site

Halifax, Nova Scotia B3H 2Y9 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Barrie, Ontario L4M 6M2 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Hamilton, Ontario L8V 5C2 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Oshawa, Ontario L1G 2B9 - Canada

Status: NOT_YET_RECRUITING

And 53 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Untreated Follicular Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships